Barchart.com
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

P A M Transport Sv (PTSI)

P A M Transport Sv (PTSI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
19.72 +0.65 (+3.41%) 11/11/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 19.72 unch (unch) -
News & Headlines for Mon, Nov 11th, 2024
Help
Go To:
P.A.M. Transportation: Q3 Earnings Snapshot AP - Thu Oct 24, 2024

P.A.M. Transportation: Q3 Earnings Snapshot

PTSI : 19.72 (+3.41%)
P.A.M. Transportation: Q2 Earnings Snapshot AP - Wed Jul 24, 2024

P.A.M. Transportation: Q2 Earnings Snapshot

PTSI : 19.72 (+3.41%)
P.A.M. Transportation: Q1 Earnings Snapshot AP - Thu Apr 18, 2024

P.A.M. Transportation: Q1 Earnings Snapshot

PTSI : 19.72 (+3.41%)
P.A.M. Transportation: Q4 Earnings Snapshot AP - Thu Feb 1, 2024

P.A.M. Transportation: Q4 Earnings Snapshot

PTSI : 19.72 (+3.41%)
Pam Transportation feels brunt of downcycle in Q3 FreightWaves - Thu Oct 19, 2023

Pam Transportation Services sees truckload fundamentals weaken further during the third quarter. The post Pam Transportation feels brunt of downcycle in Q3 appeared first on FreightWaves .

JBHT : 132.71 (+1.80%)
PTSI : 19.72 (+3.41%)
P.A.M. Transportation: Q3 Earnings Snapshot AP - Wed Oct 18, 2023

P.A.M. Transportation: Q3 Earnings Snapshot

PTSI : 19.72 (+3.41%)
Author
Pam Transportation sees earnings fall 60% in Q2 FreightWaves - Thu Jul 20, 2023

Pam Transportation Services reported a sharp decline in earnings during the second quarter. The post Pam Transportation sees earnings fall 60% in Q2 appeared first on FreightWaves .

PTSI : 19.72 (+3.41%)
P.A.M. Transportation: Q2 Earnings Snapshot AP - Wed Jul 19, 2023

P.A.M. Transportation: Q2 Earnings Snapshot

PTSI : 19.72 (+3.41%)
Author
Pam Transportation’s Q1 earnings fall by half FreightWaves - Mon Apr 24, 2023

Pam Transportation saw first-quarter earnings fall as the truckload market searches for a bottom. The post Pam Transportation’s Q1 earnings fall by half appeared first on FreightWaves .

PTSI : 19.72 (+3.41%)
P.A.M. Transportation: Q1 Earnings Snapshot AP - Mon Apr 24, 2023

P.A.M. Transportation: Q1 Earnings Snapshot

PTSI : 19.72 (+3.41%)
Oncology Breakthroughs: How Cancer Research Is Advancing in 2025 Newswire.ca - Thu Feb 27, 9:04AM CST

/CNW/ -- USA News Group News Commentary – Now that World Cancer Day (Feb. 4) has come and gone, the world and the market are looking towards what's being...

ONCY : 0.5767 (+1.78%)
GNTA : 4.05 (+5.74%)
CELC : 10.99 (-0.72%)
NYT : 50.41 (-0.06%)
SLS : 1.3400 (+2.29%)
ONC.TO : 0.79 (unch)
AMGN : 279.26 (+0.49%)
World Cancer Day Sparks Big Questions About Pollution, Genetics, and Innovation BayStreet.ca - Thu Feb 27, 8:58AM CST

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – As World Cancer Day (Feb. 4) fades into the rearview, attention is shifting to the latest discussions...

ONCY : 0.5767 (+1.78%)
ZNTL : 1.4750 (-1.67%)
NYT : 50.41 (-0.06%)
ABSI : 3.19 (+0.32%)
GOVX : 0.9688 (+14.25%)
ONC.TO : 0.79 (unch)
GSK : 37.35 (+0.86%)
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights Newswire.ca - Tue Feb 25, 6:00AM CST

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that...

ONCY : 0.5767 (+1.78%)
ONC.TO : 0.79 (unch)
Investors Eye Biotech Sector as Cancer Therapy Market Surges Newswire.ca - Wed Feb 19, 9:06AM CST

/CNW/ -- USA News Group News Commentary – Amid the excitement surrounding Project Stargate—the $500 billion investment aimed at revolutionizing AI-driven data...

ONCY : 0.5767 (+1.78%)
RENB : 0.3796 (+1.06%)
POAI : 1.0500 (+9.68%)
DGX : 175.58 (+1.16%)
GRAL : 35.93 (+6.43%)
ONC.TO : 0.79 (unch)
Oncolytics Biotech® Advances Key Pancreatic and Anal Cancer Trials, Strengthening Pipeline in 2025 Newswire.ca - Wed Feb 19, 6:00AM CST

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, continues to make...

ONCY : 0.5767 (+1.78%)
ONC.TO : 0.79 (unch)
Oncolytics Biotech® Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer FinancialNewsMedia - Tue Feb 18, 10:25AM CST

Recent clinical data presentations in these two hard-to-treat GI cancers, coupled with strong efficacy signals in breast cancer, demonstrate the potential of pelareorep across very different tumor types...

ONCY : 0.5767 (+1.78%)
ONC.TO : 0.79 (unch)
Optimism in War on Cancer on the Rise, as Biotech Companies Roll Out More Wins FinancialNewsMedia - Tue Feb 18, 10:24AM CST

Vancouver, BC – February 18, 2025 – USA News Group News Commentary – Despite optimism coming from the launch of Project Stargate (a $500 billion investment in AI data centers), there is still cause...

ONCY : 0.5767 (+1.78%)
ALLO : 1.5500 (-3.73%)
VRCA : 0.4552 (-0.76%)
ONC.TO : 0.79 (unch)
OSTX : 1.5800 (+1.94%)
IBRX : 2.65 (-1.49%)
Optimism in War on Cancer on the Rise, as Biotech Companies Roll Out More Wins BayStreet.ca - Tue Feb 18, 8:05AM CST

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Despite optimism coming from the launch of Project Stargate (a $500 billion investment in AI data centers),...

ALLO : 1.5500 (-3.73%)
ONCY : 0.5767 (+1.78%)
VRCA : 0.4552 (-0.76%)
ONC.TO : 0.79 (unch)
IBRX : 2.65 (-1.49%)
OSTX : 1.5800 (+1.94%)
Oncolytics Biotech® Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer Newswire.ca - Tue Feb 18, 6:00AM CST

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, continues to make...

ONCY : 0.5767 (+1.78%)
ONC.TO : 0.79 (unch)
Oncolytics Biotech® Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency Newswire.ca - Fri Feb 14, 4:15PM CST

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that...

ONCY : 0.5767 (+1.78%)
ONC.TO : 0.79 (unch)
Oncology Breakthroughs: How Cancer Research Is Advancing in 2025 Newswire.ca - Thu Feb 27, 9:04AM CST

/CNW/ -- USA News Group News Commentary – Now that World Cancer Day (Feb. 4) has come and gone, the world and the market are looking towards what's being...

ONCY : 0.5767 (+1.78%)
GNTA : 4.05 (+5.74%)
CELC : 10.99 (-0.72%)
NYT : 50.41 (-0.06%)
SLS : 1.3400 (+2.29%)
ONC.TO : 0.79 (unch)
AMGN : 279.26 (+0.49%)
World Cancer Day Sparks Big Questions About Pollution, Genetics, and Innovation BayStreet.ca - Thu Feb 27, 8:58AM CST

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – As World Cancer Day (Feb. 4) fades into the rearview, attention is shifting to the latest discussions...

ONCY : 0.5767 (+1.78%)
ZNTL : 1.4750 (-1.67%)
NYT : 50.41 (-0.06%)
ABSI : 3.19 (+0.32%)
GOVX : 0.9688 (+14.25%)
ONC.TO : 0.79 (unch)
GSK : 37.35 (+0.86%)
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights Newswire.ca - Tue Feb 25, 6:00AM CST

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that...

ONCY : 0.5767 (+1.78%)
ONC.TO : 0.79 (unch)
Investors Eye Biotech Sector as Cancer Therapy Market Surges Newswire.ca - Wed Feb 19, 9:06AM CST

/CNW/ -- USA News Group News Commentary – Amid the excitement surrounding Project Stargate—the $500 billion investment aimed at revolutionizing AI-driven data...

ONCY : 0.5767 (+1.78%)
RENB : 0.3796 (+1.06%)
POAI : 1.0500 (+9.68%)
DGX : 175.58 (+1.16%)
GRAL : 35.93 (+6.43%)
ONC.TO : 0.79 (unch)
Oncolytics Biotech® Advances Key Pancreatic and Anal Cancer Trials, Strengthening Pipeline in 2025 Newswire.ca - Wed Feb 19, 6:00AM CST

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, continues to make...

ONCY : 0.5767 (+1.78%)
ONC.TO : 0.79 (unch)
Oncolytics Biotech® Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer FinancialNewsMedia - Tue Feb 18, 10:25AM CST

Recent clinical data presentations in these two hard-to-treat GI cancers, coupled with strong efficacy signals in breast cancer, demonstrate the potential of pelareorep across very different tumor types...

ONCY : 0.5767 (+1.78%)
ONC.TO : 0.79 (unch)
Optimism in War on Cancer on the Rise, as Biotech Companies Roll Out More Wins FinancialNewsMedia - Tue Feb 18, 10:24AM CST

Vancouver, BC – February 18, 2025 – USA News Group News Commentary – Despite optimism coming from the launch of Project Stargate (a $500 billion investment in AI data centers), there is still cause...

ONCY : 0.5767 (+1.78%)
ALLO : 1.5500 (-3.73%)
VRCA : 0.4552 (-0.76%)
ONC.TO : 0.79 (unch)
OSTX : 1.5800 (+1.94%)
IBRX : 2.65 (-1.49%)
Optimism in War on Cancer on the Rise, as Biotech Companies Roll Out More Wins BayStreet.ca - Tue Feb 18, 8:05AM CST

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Despite optimism coming from the launch of Project Stargate (a $500 billion investment in AI data centers),...

ALLO : 1.5500 (-3.73%)
ONCY : 0.5767 (+1.78%)
VRCA : 0.4552 (-0.76%)
ONC.TO : 0.79 (unch)
IBRX : 2.65 (-1.49%)
OSTX : 1.5800 (+1.94%)
Oncolytics Biotech® Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer Newswire.ca - Tue Feb 18, 6:00AM CST

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, continues to make...

ONCY : 0.5767 (+1.78%)
ONC.TO : 0.79 (unch)
Oncolytics Biotech® Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency Newswire.ca - Fri Feb 14, 4:15PM CST

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that...

ONCY : 0.5767 (+1.78%)
ONC.TO : 0.79 (unch)

Barchart Exclusives

Unusual Options Activity: Toast Makes a Tasty LEAP for Conservative Investors Barchart - 9 minutes ago
Toast had one unusually active option on Wednesday among the 1,053 puts and calls, but it’s all the conservative investor needs to make a bet on the fast-growing restaurant software business. Here’s why. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective
Wed, Apr 30, 2025 5:00 PM UTC
Reserve Your Spot

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.

Start 30-Day Risk Free Trial